Categories: Appointment

Cytecare announces Dr. Vikram Kekatpure as Senior Consultant – Head & Neck Surgical Oncology

Bengaluru, March 01, 2017: Bengaluru-based Cytecare Cancer Hospitals today announced the appointment of Dr. Vikram Kekatpure as Senior Consultant Head & Neck Surgical Oncology. Dr. Kekatpure is are nowned oncologist with over 14 years of experience in clinical care, teaching and research. His key specialisation includes oral cancer, thyroid diseases, laryngeal cancer, skull base tumor, microvascular reconstruction and advanced head and neck tumor.

Welcoming the appointment,Mr. Suresh Ramu, CEO & Co Founder, Cytecare Hospitals, said “We are delighted to have Dr. Vikram Kekatpure on board as Consultant Head & Neck Surgical Oncology.Mr. Kekatpure brings in great value to Cytecare with his specialized and research based approach. Cytecare is looking forward to leverage his experience and years of practice in bringing innovation and strengthening the patient-centric approach of the hospital.”

Prior to joining Cytecare, Dr. Kekatpure worked as a Senior Consultant – Head and Neck Surgical Oncology and Reconstructive Surgery, at NH-Mazumdar-Shaw Medical Center, Bangalore.

Speaking on his appointment, Dr. Vikram Kekatpure said, “Cancer care in the past few years has evolved gradually in terms of treatment and diagnosis. Cytecare follows a patient friendly approach by focusing on the need and requirement of the patients by providing personalized services. I am happy to be a part of the Cytecare family and I believe that working with this hospital will help me leverage my experience to push Cytecare’s endeavour in creating a more patient-centric cancer care system.”

Dr. Kekatpure has received several awards including the noteworthy Scholar-in-Training award from the AACR and from FHNO for his research paper.Some of his papers provide insights on issues like oral cavity and reconstruction options, laryngeal cancers, mid face reconstruction, head and neck reconstruction etc.He is an active member of various influential medical societies nationally and internationally like the Foundation for Head and Neck Oncology India (FHNO), Indian Association of Cancer Research, American Association of Cancer Research (AACR), AO foundation and the Head and Neck Cooperative Oncology Group.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

SOULFLOWER LAUNCHES INDIA’S 1ST CLINICALLY PROVEN ROSEMARY REDENSYL HAIR GROWTH SERUM (TETRAGAIN™)

Breakthrough Formulation Helps Reduce Hair Fall By 64.89%, Enhance Hair Growth & Address Premature Greying…

11 hours ago

Neuberg Diagnostics secures INR 940 crores from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector

New Delhi, January 15, 2025: Neuberg Diagnostics, founded in 2017 and headquartered in Chennai, has rapidly…

11 hours ago

World’s First Robotic Cardiac Telesurgeries Performed Over a Distance of 286 Km Using Made-in-India Surgical Robotic System, SSI Mantra

·         The Telerobotic-assisted Internal Mammary Artery Harvesting procedure was successfully completed in 58 minutes, with exceptional precision and…

2 days ago

DFE Pharma expands its C2F Center of Excellence to advance the development of critical respiratory treatments

This expansion enables DFE Pharma to offer specialized analytical services for Dry Powder Inhalation (DPI)…

2 days ago

A Growing Threat: Navigating HMPV and Emerging Respiratory Illnesses in Children

Dr. Sujatha Thyagarajan, Lead & HOD - Pediatric Intensive Care and Pediatric Emergency at Aster…

2 days ago

Software Engineer from Malaysia undergoes Robotic Direct Anterior Hip Replacement Surgery at Fortis Hospital Bannerghatta Road

Bangalore, January 13, 2025: Fortis Hospital Bannerghatta Road, has successfully treated a 53-year-old software engineer from…

2 days ago